Sienna Venture Capital

Glad to share that our portfolio company Ibex Medical Analytics is expanding its partnership with Philips to advance AI pathology workflows and improve patient outcomes.   This collaboration brings AI deeper into digital pathology, helping labs work faster and more accurately. « Ibex's AI and Philips’ digital pathology solution have shown to improve reporting efficiency and drive productivity gains of up to 37%. »   Learn more about this milestone below.   GBL (Groupe Bruxelles Lambert) Isabelle Amiel Azoulai Thomas Visan Joseph (Yossi) Mossel Chaim Linhart

Glad to announce that our portfolio company Nexar Inc. is partnering with NVIDIA to build the future of Autonomous Vehicles. For years, AV models have relied on synthetic data; useful but limited in capturing the unpredictability of real-world driving. Nexar Inc. changes that. With over 100 million miles of driving data captured every month, they provide the real-world scenarios essential for training safer and smarter AV models. Combining Nexar’s dataset with NVIDIA models will take Autonomous Vehicle solutions to the next level. Read more about this milestone below. GBL (Groupe Bruxelles Lambert) Isabelle Amiel Azoulai Zach Greenberger Eran Shir Bruno Fernandez-Ruiz

𝗖𝗹𝗮𝘀𝘀 𝗶𝘀 𝗶𝗻 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 - Mikael 𝘁𝗿𝗮𝗱𝗲𝗱 𝗵𝗶𝘀 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗵𝗮𝘁 𝗳𝗼𝗿 𝗮 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗼𝗿’𝘀 𝗰𝗮𝗽! 🧑🏫 Sienna Venture Capital is glad to have hosted a session presenting our fund and giving a course on venture capital in front of 50 bright students from HKU Business School! As European investors deeply involved in Israeli tech, it was exciting to share insights on what makes this ecosystem unique and how we back high-growth startups scaling globally. The engagement, sharp questions, and curiosity from the students made it a truly dynamic discussion! From investment frameworks to scaling strategies, we covered what it takes to navigate the VC landscape. Looking forward to staying connected with these future investors and entrepreneurs! Isabelle Amiel Azoulai #VentureCapital #TechInvestment #HKU #IsraeliTech #StartupEcosystem

Sienna Venture Capital and Thomas Visan are featured in CTech by Calcalist! Europe’s reputation for heavy regulation often overshadows the massive opportunities it offers for Israeli startups. At Sienna, we believe the region is becoming a prime market for deeptech, AI, and cybersecurity companies looking to scale globally. Read more about why Europe is a key growth hub for Israeli innovation 👇

Sienna Venture Capital is glad to announce that its portfolio company Ibex Medical Analytics has received its first FDA 510(k) clearance. This regulatory milestone validates Ibex breakthrough AI-powered solution, enhancing accuracy in cancer detection and supporting pathologists in delivering more precise diagnoses. As the demand for diagnostic solutions continues to grow, AI tools like Ibex’s are instrumental in improving patient outcomes and shaping the future of digital pathology. We are proud to support Ibex on its journey to transforming cancer diagnostics worldwide. Congrats to the Ibex team! Joseph (Yossi) Mossel Chaim Linhart #AI #HealthcareInnovation #CancerDiagnostics #SiennaVC #IbexMedicalAnalytics

🌟 𝗧𝗵𝗲 𝘄𝗵𝗼𝗹𝗲 𝗦𝗶𝗲𝗻𝗻𝗮 𝗩𝗖 𝘁𝗲𝗮𝗺 𝘄𝗶𝘀𝗵𝗲𝘀 𝘆𝗼𝘂 𝗮 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝗡𝗲𝘄 𝗬𝗲𝗮𝗿! 𝗟𝗲𝘁’𝘀 𝘁𝗮𝗸𝗲 𝗮 𝗺𝗼𝗺𝗲𝗻𝘁 𝘁𝗼 𝗰𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗲 𝗼𝘂𝗿 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲𝘀 𝗮𝗻𝗱 𝗹𝗼𝗼𝗸 𝗮𝗵𝗲𝗮𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗮𝘄𝗮𝗶𝘁𝗶𝗻𝗴 𝘂𝘀 𝗶𝗻 𝟮𝟬𝟮𝟱. 🌟   ✅ 𝗡𝗲𝘄 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 In 2024, we achieved our first closing, marking a key milestone in our fundraising journey, and successfully completed 4 transactions, bringing our total to 7 invested companies: - An investment in Unleash, a Gen-AI based software revolutionizing how enterprises from any vertical can leverage their data - 3 follow-on rounds to support and scale our portfolio companies   🏆 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗦𝘁𝗼𝗿𝗶𝗲𝘀 Unleash: Achieving incredible growth and featured in the recent Insight Partners mapping Nexar Inc.: Strengthening its position as a vision AI leader with 2 recent partnerships announced with Lyft and Waymo Incredo: Scaling the commercialization of its sugar-reduction solution, growing from 3 to 23 product lines across the US SupPlant: Securing multiple contracts in the UAE, proving the global impact of its Agtech solutions especially in dry regions   🙌 𝟮𝟬𝟮𝟰 𝘄𝗮𝘀 𝗮𝗹𝘀𝗼 𝗺𝗮𝗿𝗸𝗲𝗱 𝗯𝘆 𝗸𝗲𝘆 𝗲𝘃𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 - Speakers in SIAL Paris 2024, Middle East Investors Summit, and Wealth Tech Day, as well as hosting an event in our offices with Incredo and a panel on Israeli Innovation for a Healthier Tomorrow (Thank you again Kelly, Christina, & Gil!) - Receiving the CCFI - Chambre de Commerce France Israel Award, honoring our commitment to strengthening ties between France and Israel through 50+ investments in Israeli tech   At the heart of these accomplishments lies our “Tech for Purpose” mission, which was deeply reinforced during a meaningful journey to Israel at the start of 2024, a pivotal time that reminded us of the real-world impact we strive to create through innovation.   🤔 𝗪𝗵𝗮𝘁’𝘀 𝗻𝗲𝘅𝘁 𝗳𝗼𝗿 𝟮𝟬𝟮𝟱? Building on the momentum of this year, we plan to strengthen our teams, finalize our second closing, and execute new investments.   A big up to our entrepreneurs, investors, and partners for your trust and collaboration. Together, let’s make 2025 a record-breaking year 🚀 Isabelle Thomas Mikael Jacques Paul-Louis Violette GBL (Groupe Bruxelles Lambert)

Season's greetings from Sienna VC! ⭐🎄

𝐈𝐬𝐫𝐚𝐞𝐥𝐢 𝐡𝐢𝐠𝐡-𝐭𝐞𝐜𝐡 𝐞𝐱𝐢𝐭𝐬 𝐡𝐢𝐭 $𝟏𝟑.𝟒𝐁 𝐢𝐧 𝟐𝟎𝟐𝟒 👉 A 78% increase compared to $7.5B in 2023 👉 Eight mega-deals over $500M totalled $6.8B 👉 Cyber & AI led the pack 👉 US buyers dominated with $8.9B across 31 deals (58% of the total), followed by Israeli & European buyers Full article in the comment! CTech by Calcalist

Great job, Unleash team! 🎉 If you're looking to transform the way your team accesses and shares knowledge, Unleash is the solution you need. Instant answers, seamless integration, and enterprise-grade security—don’t wait to see what they can do for your business! #AI #Innovation #Tech

Congrats Isabelle Amiel Azoulai and team! Thomas Visan Mikael Pereira Paul-Louis Bisbarre Violette Doncieux